MINI FUTURE SHORT - JOHNSON & JOHNSON Share Price

Certificat

U7KDB

NLBNPNL1FLF7

Market Closed - Euronext Paris 17:30:01 14/05/2024 BST
5.312 EUR -0.62% Intraday chart for MINI FUTURE SHORT - JOHNSON & JOHNSON
Current month-9.12%
1 month-5.73%
Date Price Change
14/05/24 5.312 -0.62%
13/05/24 5.345 -1.94%
10/05/24 5.451 +0.13%
09/05/24 5.444 -1.09%
08/05/24 5.504 +0.31%

Real-time Euronext Paris

Last update May 14, 2024 at 05:30 pm

More quotes

Static data

Product typeKnock-Out mit Stop Loss
Buy / SellPUT
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer BNP Paribas BNP Paribas
U7KDB
ISINNLBNPNL1FLF7
Date issued 08/09/2021
Strike 208.2 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.67
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 6.065
Lowest since issue 2.45

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
151.4 USD
Average target price
173.3 USD
Spread / Average Target
+14.46%
Consensus
  1. Stock Market
  2. Certificates
  3. U7KDB Certificat